In March 2025, the company announced new options to get a immediate-to-consumer offering of its Wegovy weight loss drug. The company proven a different pharmacy, identified as NovoCare, which might cost prospects $499 a month for usage of the drug, a lot less than 50 % the price of the drug by means of other pharmaceutical distribution networks.[53